Product/Composition:- | Prilocaine + Lidocaine Creams and Ointments |
---|---|
Strength:- | 2.5%, 5%, 7% (prilocaine); 2.5% lidocaine |
Form:- | Creams and Ointments |
Reference Brands:- | EMLA, Oraqix, Ametop(US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Prilocaine + Lidocaine creams and ointments block nerve signals by reversibly inhibiting sodium channels, providing localized anesthesia. Benefits include rapid onset, effective pain relief in minor dermatological or procedural applications, minimal systemic side effects, and targeted numbness, making them ideal for small surgeries, injections, or skin irritations.
Prilocaine + lidocaine creams and ointments are approved in the EU and US for topical anesthesia in dermatological, dental, and minor surgical procedures. In the EU, brands like EMLA are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on comprehensive clinical data, with many generic formulations available. Both regions require detailed dossiers for approval and ongoing pharmacovigilance. For regulatory support, dossier preparation, and compliance, visit PharmaTradz. We facilitate seamless market access for prilocaine + lidocaine formulations, ensuring adherence to European and American standards for safe, effective topical anesthesia, navigating complex regulatory landscapes seamlessly.